Clinical Trial Update: Study of Everolimus in de Novo Renal Transplant Recipients [NA]

View source ↗

Summary

This is a clinical trial update on everolimus in de novo renal transplant recipients; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Helady Pinheiro, MD, PhD | Conditions: End Stage Renal Failure With Renal Transplant | NA | Status: TERMINATED